Schedule 13G ownership disclosure

Coherus Oncology Inc

Security class unavailable · CUSIP: 19249H103

Event date: Unavailable

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
4,128,935
Percent of class
5.7300%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-21-017790
Form type
SC 13G
Filer
Coherus Oncology, Inc.
CIK
CIK 1512762
Filed
Feb 10, 2021
Reporting period
—
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub